Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992;109(3):321-30.
doi: 10.1007/BF02245880.

Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests

Affiliations

Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests

A Ennaceur et al. Psychopharmacology (Berl). 1992.

Abstract

The effects of physostigmine and scopolamine were evaluated on working memory of rats in object recognition and radial-maze tests. Three doses of physostigmine hemi-sulfate (Phys: 0.05, 0.10 and 0.20 mg/kg), five doses of scopolamine hydrobromide (Scop: 0.125, 0.25, 0.5, 1.0 and 2.0 mg/kg), and one dose of scopolamine methylbromide (Mscop: 2.0 mg/kg) were used. In object recognition test, rats were submitted to three or four intertrial delay conditions (1-min, 15-min and either 60-min or 24-h). The higher doses of Scop (1.0 and 2.0 mg/kg) in 1-min and 15-min delay and of Phys (0.20 mg/kg) in 1-min delay impaired discrimination between new and familiar objects. Mscop impaired discrimination between objects in 60-min but not in 1-min and 15-min delay. This effect may be state dependent. Radial-maze learning was impaired by the lower doses of scopolamine (0.25 and 0.50 mg/kg) which had no effect in object recognition test. These results show that in our conditions, object recognition is less sensitive than radial-maze test to cholinergic drugs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Trends Neurosci. 1991 Jun;14(6):220-3 - PubMed
    1. Pharmacol Biochem Behav. 1989 Jan;32(1):309-15 - PubMed
    1. Behav Brain Res. 1988 Nov 1;31(1):47-59 - PubMed
    1. Q J Exp Psychol B. 1987 Nov;39(4):297-314 - PubMed
    1. Psychopharmacology (Berl). 1988;96(4):541-6 - PubMed

LinkOut - more resources